All In MedTech

Company

Ascensia Diabetes Care

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 21, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Ascensia Diabetes Care, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

No 5%+ shareholder filings, SBIR grants or venture investors found under the name Ascensia Diabetes Care.

Latest FDA decisions

The 8 newest of 13 since 2015.

Search the Clearance Tracker

12 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

40 more trials with a free account

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2321100
Jan 2413000
Feb 2412100
Mar 2421400
Apr 2417100
May 2413200
Jun 2419200
Jul 2417000
Aug 2419000
Sep 2412000
Oct 2413000
Nov 2412100
Dec 2414100
Jan 2515300
Feb 2510000
Mar 2522200
Apr 2511200
May 2515100
Jun 2518000
Jul 2513100
Aug 2513000
Sep 2517000
Oct 2510200
Nov 254000
Dec 257000
Jan 263100
Feb 267100
Mar 261000
Apr 2610000
May 263000
Jun 268000
Jul 263000
Aug 266200
Sep 2611400
Oct 263000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

The full in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Z-2211-2023 · Started May 19, 2023 · Posted by FDA Jul 20, 2023

    Reason given: Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display...

    Cause as FDA categorized it: Process control · Device type: System, Test, Blood Glucose, Over The Counter (NBW)

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.